Damages Back In Play In Pfizer Patent Suit
A federal judge has reconsidered his ruling in a patent infringement dispute over Pfizer Inc.'s Accupril, deciding to put some potential damages against defendants Ranbaxy Laboratories Ltd. and Teva Pharmaceuticals USA...To view the full article, register now.
Already a subscriber? Click here to view full article